Antibiotic resistance is a bacterial defense mechanism against antibiotics. It can rapidly spread from one bacterium to another. This makes antibiotics increasingly ineffective.
Detailed description
The level of resistances against antibiotics is rising. This is a great challenge for physicians and scientists. Scientists within the DZIF research field “Healthcare-associated and Antibiotic-resistant bacterial Infections” aim to develop new strategies against the development and spread of resistance.
DZIF scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have succeeded in identifying and targeting problematic pathogens in biofilms more rapidly. The biofilm adhesion
World Tuberculosis Day on 24 March is a reminder to the public that 1.5 people still die of tuberculosis (TB) every year. The rise of multidrug-resistant strains is particularly problematic, currently
Scientists led by the Leibniz Research Center Borstel, the Institute of Microbiology and Laboratory Diagnostics in Gauting, the Institute of Medical Microbiology of the University of Zurich and the
Researchers from the German Center for Infection Research (DZIF) and the University of Giessen have shown that the gene for resistance to colistin, which was recently discovered in China, also exists
His aim is to develop a vaccine against the widespread gastric pathogenHelicobacter pylori: for his work in this field, Professor Markus Gerhard, Technische Universität München (TUM), was awarded the
Infectious diseases are a leading cause of death worldwide. Current problems such as antibiotic resistance, declining vaccination rates and emerging infections like Ebola present scientists and
Scientists from the Research Center Borstel, the German Center for Infection Research, the Oxford Biomedical Research Centre and the South African National Institute for Communicable Diseases have
The German Center for Infection Research (DZIF) is growing: three new member establishments will now be supporting the DZIF in its research activities, the Friedrich-Loeffler-Institut (FLI), the
According to figures of the World Health Organization, some 8.7 million people contracted tuberculosis in 2012 and this disease is fatal for approximately 1.3 million people throughout the world each
In the DZIF, scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded
